Founded

Address

Vivaldi Biosciences Inc
Bellevue Hospital Center
462 First Avenue Bldg A Suite 908
New York, NY 10016
United States

Open map

Phone
KANDO id: 348258

Corporate information

Registration country

Official identities

US CIK 0001398022

Company type

Developing novel genetically modified vaccines to protect against common seasonal influenza and emergent pandemic influenza.

Funding rounds

Profile Country
Bay City Capital LLC

Profile Country
NGN Capital LLC


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials